CellAct Pharma
BioMedizinZentrum
Otto-Hahn-Str. 15
Dortmund
D-44227
Germany
Tel: 49-231-97426350
Fax: 49-231-97426355
Website: http://www.cellact.eu/
Email: info@cellact.eu
5 articles about CellAct Pharma
-
Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma
8/15/2017
-
ASCO2016: CellAct Pharma Phase II CAP7.1 Population Pharmacokinetic Data Supports Efficacy Results In Biliary Tract Cancers
6/3/2016
-
CellAct Pharma Receives Orphan Drug Designation In EU For CAP7.1 In Biliary Tract Cancers
7/15/2014
-
CellAct Pharma's Topoisomerase Inhibitor Demonstrates Success in Phase I Study Involving Adults With Heavily Pretreated Solid Tumors
11/12/2012
-
CellAct Pharma Advances Phase I Clinical Trial of Topoisomerase Inhibitor in Cancer
10/16/2009